Diclofenac associated with cardiovascular health risk

0
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...

New alliance between PSA and SHPA announced

0
At PSA19 this morning, it was revealed that a Memorandum of Understanding (MoU) was signed by PSA and the Society of Hospital Pharmacists of...

Case study: How Anh solved her son’s problem headaches

0
If your patient is struggling with persistent headaches and sinus pain, allergies could be the cause.

Complementary medicines during cold and flu season

0
As cold and flu season reaches fever pitch, the demand for complementary medicines to help prevent and manage colds and influenza is increasing. A...

Transforming medicine safety in aged care

0
PSA’s 2025 Early Career Pharmacist of the Year, Dr Kate Wang is shaping pharmacy education and aged care policy.

TGA changes continue to impact and sometimes baffle pharmacists

0
A number of recent decisions by the Therapeutic Goods Administration (TGA) are highly relevant to pharmacists in Australia. Firstly, the interim decision from the...